SPHERA FUNDS MANAGEMENT LTD.

CIK

1496201

City

TEL AVIV

State / Country

L3

Stock

JSPR — Jasper Therapeutics, Inc.

Top Portfolio Positions

91 positions · $591,353,809 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio	Open
MLYS	Mineralys Therapeutics, Inc. Healthcare	1,339,971	$36,299,814	6.14%
TEVA	Teva Pharmaceutical Industries Ltd Healthcare	1,136,975	$34,245,687	5.79%
TSEM	Tower Semiconductor Ltd Technology	145,735	$25,573,577	4.32%
NVMI	Nova Ltd. Technology	53,366	$23,175,786	3.92%
CYTK	Cytokinetics Inc Healthcare	299,117	$19,714,801	3.33%
BBIO	BridgeBio Pharma, Inc. Healthcare	245,246	$18,211,967	3.08%
BIIB	Biogen Inc. Healthcare	92,526	$16,962,791	2.87%
RARE	Ultragenyx Pharmaceutical Inc. Healthcare	809,333	$16,955,526	2.87%
SNDX	Syndax Pharmaceuticals Inc Healthcare	724,563	$16,925,791	2.86%
COGT	Cogent Biosciences, Inc. Healthcare	416,340	$16,024,926	2.71%

Portfolio Trend

25 quarters · across all stocks

Holdings in JSPR

Compact Export CSV

Shares Held

Position Value (USD)

11 quarters on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2025-12-31	$888,283	485,401	-22.9%	Shares	Defined	2026-02-17
2025-09-30	$1,498,138	629,470	+4190.6%	Shares	Defined	2025-11-14
2025-06-30	$81,424	14,671	-88.0%	Shares	Defined	2025-08-14
2025-03-31	$524,673	122,017	+57.4%	Shares	Defined	2025-05-15
2024-12-31	$1,656,950	77,500	-42.9%	Put	Defined	2025-02-14
2024-12-31	$2,901,693	135,720	+122.1%	Shares	Defined	2025-02-14
2024-12-31	$1,306,318	61,100	0.0%	Call	Defined	2025-02-14
2024-09-30	$1,149,291	61,100	-67.7%	Call	Defined	2024-11-14
2024-09-30	$3,560,168	189,270	-58.3%	Shares	Defined	2024-11-14
2024-06-30	$10,310,952	454,227	-10.1%	Shares	Defined	2024-08-14
2024-03-31	$14,833,905	505,242	—	Shares	Defined	2024-05-15
No 13F history on record for this holder in this stock.